If you or someone you know has chronic asthma do read this article to know how biologics can potentially help in treating the condition ...

The FDA warns that longtime users of popular allergy medications may experience "severe itching" after stopping use.

New findings from the MATINEE and COPD-HELP studies suggest mepolizumab could reduce exacerbations and improve quality of ...

Patients with moderate to severe asthma saw increases in FEV1 within 24 hours after taking a loading dose of rademikibart, ...

Tezepelumab demonstrated clinically relevant benefits in specific inflammatory subtypes of COPD - an historically underserved ...

Allergic and/or T2 inflammatory biomarkers are more common in patients with asthma or asthma-COPD overlap vs in patients with COPD alone.

Allergy season is here and many feeling more intense effects of their symptoms right now.According to Dr. Sohaib Aleem, an ...

This World EoE Day – the first ever – we’re encouraging people around the globe to spread awareness of EoE and talk to a doctor if they recognize symptoms of EoE in themselves or a loved one.” — Mary ...

Scientists say study findings indicate that TC IV cells may represent a therapeutic target for the treatment of ...

Eosinophilic esophagitis (EoE) is a multifaceted disease marked by diverse clinical features, including variations in age of onset, symptom ...

Elle Dunn just wanted clear skin before her sister's wedding — instead, her body started shutting down from a rare allergic ...

The dynamics of the eosinophilic esophagitis market are anticipated to change in the coming years owing to the expected launch of emerging therapies such as APT-1011 (Ellodi Pharmaceuticals) ...